Pharma & Biotech Patent Litigation USA & Canada 2026
Organized by C5 Communications (C5 Group)
The conference brings together life sciences patent litigation leaders from across the US and Canada for three days of practical strategy, cross-border insight, and candi...
- Dates
- Oct 14-16, 2026
- Location
- New York, NY
- Deadline
- Sep 30, 2026
- Attendees
- 2,000
- Vendors
- Unlock to view
About this conference
The conference brings together life sciences patent litigation leaders from across the US and Canada for three days of practical strategy, cross-border insight, and candid discussion on the issues reshaping life sciences IP litigation. It covers topics such as skinny labeling, §112 challenges, GLP-1 litigation, trade secrets, AI ethics, forum strategy, emerging technologies, UPC developments, and the global impact of decisions like Hikma v Amarin and BSH v Electrolux. Attendees will gain insights into new theories in patent litigation, substantive case law, and practical litigation strategies for patent trials and related proceedings, focusing on challenges and successes of patent litigators in pharma and biotech.
Sponsorship options
Sponsor Opportunities and Global Sponsorship Opportunities are available to maximize participation or showcase organizational services and talent.
Attendee roles and functions
Roles and teams represented at Pharma & Biotech Patent Litigation USA & Canada
Find contacts by role
Conference verticals
Public-sector and commercial markets covered by this event
Vendors at this conference
Unlock full vendor list
See sponsors, exhibitors, and vendors attending this conference.